The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Aurora Kinase A Market Research Report 2024

Global Aurora Kinase A Market Research Report 2024

Publishing Date : Oct, 2021

License Type :
 

Report Code : 1405640

No of Pages : 114

Synopsis
The global Aurora Kinase A market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Aurora Kinase A volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Aurora Kinase A market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Aurora Kinase A Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
AMG-900
Danusertib
ENMD-2076
Ilorasertib
Others

Segment by Application
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Brain Tumor
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
AbbVie Inc.
Amgen Inc.
Astex Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co., Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.
Index
1 Aurora Kinase A Market Overview
1.1 Product Overview and Scope of Aurora Kinase A
1.2 Aurora Kinase A Segment by Type
1.2.1 Global Aurora Kinase A Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 AMG-900
1.2.3 Danusertib
1.2.4 ENMD-2076
1.2.5 Ilorasertib
1.2.6 Others
1.3 Aurora Kinase A Segment by Application
1.3.1 Global Aurora Kinase A Sales Comparison by Application: (2021-2027)
1.3.2 Ovarian Cancer
1.3.3 Anaplastic Large Cell Lymphoma
1.3.4 Brain Tumor
1.3.5 Others
1.4 Global Aurora Kinase A Market Size Estimates and Forecasts
1.4.1 Global Aurora Kinase A Revenue 2016-2027
1.4.2 Global Aurora Kinase A Sales 2016-2027
1.4.3 Aurora Kinase A Market Size by Region: 2016 Versus 2021 Versus 2027

2 Aurora Kinase A Market Competition by Manufacturers
2.1 Global Aurora Kinase A Sales Market Share by Manufacturers (2016-2021)
2.2 Global Aurora Kinase A Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Aurora Kinase A Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Aurora Kinase A Manufacturing Sites, Area Served, Product Type
2.5 Aurora Kinase A Market Competitive Situation and Trends
2.5.1 Aurora Kinase A Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Aurora Kinase A Players Market Share by Revenue
2.5.3 Global Aurora Kinase A Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Aurora Kinase A Retrospective Market Scenario by Region
3.1 Global Aurora Kinase A Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Aurora Kinase A Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Aurora Kinase A Market Facts & Figures by Country
3.3.1 North America Aurora Kinase A Sales by Country
3.3.2 North America Aurora Kinase A Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Aurora Kinase A Market Facts & Figures by Country
3.4.1 Europe Aurora Kinase A Sales by Country
3.4.2 Europe Aurora Kinase A Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Aurora Kinase A Market Facts & Figures by Region
3.5.1 Asia Pacific Aurora Kinase A Sales by Region
3.5.2 Asia Pacific Aurora Kinase A Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Aurora Kinase A Market Facts & Figures by Country
3.6.1 Latin America Aurora Kinase A Sales by Country
3.6.2 Latin America Aurora Kinase A Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Aurora Kinase A Market Facts & Figures by Country
3.7.1 Middle East and Africa Aurora Kinase A Sales by Country
3.7.2 Middle East and Africa Aurora Kinase A Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Aurora Kinase A Historic Market Analysis by Type
4.1 Global Aurora Kinase A Sales Market Share by Type (2016-2021)
4.2 Global Aurora Kinase A Revenue Market Share by Type (2016-2021)
4.3 Global Aurora Kinase A Price by Type (2016-2021)

5 Global Aurora Kinase A Historic Market Analysis by Application
5.1 Global Aurora Kinase A Sales Market Share by Application (2016-2021)
5.2 Global Aurora Kinase A Revenue Market Share by Application (2016-2021)
5.3 Global Aurora Kinase A Price by Application (2016-2021)

6 Key Companies Profiled
6.1 AbbVie Inc.
6.1.1 AbbVie Inc. Corporation Information
6.1.2 AbbVie Inc. Description and Business Overview
6.1.3 AbbVie Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AbbVie Inc. Aurora Kinase A Product Portfolio
6.1.5 AbbVie Inc. Recent Developments/Updates
6.2 Amgen Inc.
6.2.1 Amgen Inc. Corporation Information
6.2.2 Amgen Inc. Description and Business Overview
6.2.3 Amgen Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Amgen Inc. Aurora Kinase A Product Portfolio
6.2.5 Amgen Inc. Recent Developments/Updates
6.3 Astex Pharmaceuticals, Inc.
6.3.1 Astex Pharmaceuticals, Inc. Corporation Information
6.3.2 Astex Pharmaceuticals, Inc. Description and Business Overview
6.3.3 Astex Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
6.3.5 Astex Pharmaceuticals, Inc. Recent Developments/Updates
6.4 CASI Pharmaceuticals Inc.
6.4.1 CASI Pharmaceuticals Inc. Corporation Information
6.4.2 CASI Pharmaceuticals Inc. Description and Business Overview
6.4.3 CASI Pharmaceuticals Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CASI Pharmaceuticals Inc. Aurora Kinase A Product Portfolio
6.4.5 CASI Pharmaceuticals Inc. Recent Developments/Updates
6.5 Merck & Co., Inc.
6.5.1 Merck & Co., Inc. Corporation Information
6.5.2 Merck & Co., Inc. Description and Business Overview
6.5.3 Merck & Co., Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Merck & Co., Inc. Aurora Kinase A Product Portfolio
6.5.5 Merck & Co., Inc. Recent Developments/Updates
6.6 Millennium Pharmaceuticals, Inc.
6.6.1 Millennium Pharmaceuticals, Inc. Corporation Information
6.6.2 Millennium Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Product Portfolio
6.6.5 Millennium Pharmaceuticals, Inc. Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Aurora Kinase A Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Sareum Holdings Plc
6.8.1 Sareum Holdings Plc Corporation Information
6.8.2 Sareum Holdings Plc Description and Business Overview
6.8.3 Sareum Holdings Plc Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sareum Holdings Plc Aurora Kinase A Product Portfolio
6.8.5 Sareum Holdings Plc Recent Developments/Updates
6.9 Sigma-Tau S.p.A.
6.9.1 Sigma-Tau S.p.A. Corporation Information
6.9.2 Sigma-Tau S.p.A. Description and Business Overview
6.9.3 Sigma-Tau S.p.A. Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Sigma-Tau S.p.A. Aurora Kinase A Product Portfolio
6.9.5 Sigma-Tau S.p.A. Recent Developments/Updates
6.10 Taiho Pharmaceutical Co., Ltd.
6.10.1 Taiho Pharmaceutical Co., Ltd. Corporation Information
6.10.2 Taiho Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product Portfolio
6.10.5 Taiho Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Vertex Pharmaceuticals Incorporated
6.11.1 Vertex Pharmaceuticals Incorporated Corporation Information
6.11.2 Vertex Pharmaceuticals Incorporated Aurora Kinase A Description and Business Overview
6.11.3 Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Vertex Pharmaceuticals Incorporated Aurora Kinase A Product Portfolio
6.11.5 Vertex Pharmaceuticals Incorporated Recent Developments/Updates
6.12 Vichem Chemie Research Ltd.
6.12.1 Vichem Chemie Research Ltd. Corporation Information
6.12.2 Vichem Chemie Research Ltd. Aurora Kinase A Description and Business Overview
6.12.3 Vichem Chemie Research Ltd. Aurora Kinase A Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Vichem Chemie Research Ltd. Aurora Kinase A Product Portfolio
6.12.5 Vichem Chemie Research Ltd. Recent Developments/Updates

7 Aurora Kinase A Manufacturing Cost Analysis
7.1 Aurora Kinase A Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Aurora Kinase A
7.4 Aurora Kinase A Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Aurora Kinase A Distributors List
8.3 Aurora Kinase A Customers

9 Aurora Kinase A Market Dynamics
9.1 Aurora Kinase A Industry Trends
9.2 Aurora Kinase A Growth Drivers
9.3 Aurora Kinase A Market Challenges
9.4 Aurora Kinase A Market Restraints

10 Global Market Forecast
10.1 Aurora Kinase A Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Aurora Kinase A by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Aurora Kinase A by Type (2022-2027)
10.2 Aurora Kinase A Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Aurora Kinase A by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Aurora Kinase A by Application (2022-2027)
10.3 Aurora Kinase A Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Aurora Kinase A by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Aurora Kinase A by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Aurora Kinase A Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Aurora Kinase A Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Aurora Kinase A Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Aurora Kinase A Covered in This Study
Table 5. Global Aurora Kinase A Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Aurora Kinase A Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Aurora Kinase A Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Aurora Kinase A Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Aurora Kinase A Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Aurora Kinase A Manufacturing Sites and Area Served
Table 11. Manufacturers Aurora Kinase A Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Aurora Kinase A by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aurora Kinase A as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Aurora Kinase A Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Aurora Kinase A Sales Market Share by Region (2016-2021)
Table 17. Global Aurora Kinase A Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Aurora Kinase A Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Aurora Kinase A Sales Market Share by Country (2016-2021)
Table 20. North America Aurora Kinase A Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Aurora Kinase A Revenue Market Share by Country (2016-2021)
Table 22. Europe Aurora Kinase A Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Aurora Kinase A Sales Market Share by Country (2016-2021)
Table 24. Europe Aurora Kinase A Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Aurora Kinase A Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Aurora Kinase A Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Aurora Kinase A Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Aurora Kinase A Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Aurora Kinase A Revenue Market Share by Region (2016-2021)
Table 30. Latin America Aurora Kinase A Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Aurora Kinase A Sales Market Share by Country (2016-2021)
Table 32. Latin America Aurora Kinase A Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Aurora Kinase A Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Aurora Kinase A Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Aurora Kinase A Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Aurora Kinase A Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Aurora Kinase A Revenue Market Share by Country (2016-2021)
Table 38. Global Aurora Kinase A Sales (K Pcs) by Type (2016-2021)
Table 39. Global Aurora Kinase A Sales Market Share by Type (2016-2021)
Table 40. Global Aurora Kinase A Revenue (Million US$) by Type (2016-2021)
Table 41. Global Aurora Kinase A Revenue Share by Type (2016-2021)
Table 42. Global Aurora Kinase A Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Aurora Kinase A Sales (K Pcs) by Application (2016-2021)
Table 44. Global Aurora Kinase A Sales Market Share by Application (2016-2021)
Table 45. Global Aurora Kinase A Revenue (Million US$) by Application (2016-2021)
Table 46. Global Aurora Kinase A Revenue Share by Application (2016-2021)
Table 47. Global Aurora Kinase A Price (USD/Pcs) by Application (2016-2021)
Table 48. AbbVie Inc. Corporation Information
Table 49. AbbVie Inc. Description and Business Overview
Table 50. AbbVie Inc. Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. AbbVie Inc. Aurora Kinase A Product
Table 52. AbbVie Inc. Recent Developments/Updates
Table 53. Amgen Inc. Corporation Information
Table 54. Amgen Inc. Description and Business Overview
Table 55. Amgen Inc. Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Amgen Inc. Aurora Kinase A Product
Table 57. Amgen Inc. Recent Developments/Updates
Table 58. Astex Pharmaceuticals, Inc. Corporation Information
Table 59. Astex Pharmaceuticals, Inc. Description and Business Overview
Table 60. Astex Pharmaceuticals, Inc. Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Astex Pharmaceuticals, Inc. Aurora Kinase A Product
Table 62. Astex Pharmaceuticals, Inc. Recent Developments/Updates
Table 63. CASI Pharmaceuticals Inc. Corporation Information
Table 64. CASI Pharmaceuticals Inc. Description and Business Overview
Table 65. CASI Pharmaceuticals Inc. Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. CASI Pharmaceuticals Inc. Aurora Kinase A Product
Table 67. CASI Pharmaceuticals Inc. Recent Developments/Updates
Table 68. Merck & Co., Inc. Corporation Information
Table 69. Merck & Co., Inc. Description and Business Overview
Table 70. Merck & Co., Inc. Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Merck & Co., Inc. Aurora Kinase A Product
Table 72. Merck & Co., Inc. Recent Developments/Updates
Table 73. Millennium Pharmaceuticals, Inc. Corporation Information
Table 74. Millennium Pharmaceuticals, Inc. Description and Business Overview
Table 75. Millennium Pharmaceuticals, Inc. Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Millennium Pharmaceuticals, Inc. Aurora Kinase A Product
Table 77. Millennium Pharmaceuticals, Inc. Recent Developments/Updates
Table 78. Sanofi Corporation Information
Table 79. Sanofi Description and Business Overview
Table 80. Sanofi Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Sanofi Aurora Kinase A Product
Table 82. Sanofi Recent Developments/Updates
Table 83. Sareum Holdings Plc Corporation Information
Table 84. Sareum Holdings Plc Description and Business Overview
Table 85. Sareum Holdings Plc Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Sareum Holdings Plc Aurora Kinase A Product
Table 87. Sareum Holdings Plc Recent Developments/Updates
Table 88. Sigma-Tau S.p.A. Corporation Information
Table 89. Sigma-Tau S.p.A. Description and Business Overview
Table 90. Sigma-Tau S.p.A. Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Sigma-Tau S.p.A. Aurora Kinase A Product
Table 92. Sigma-Tau S.p.A. Recent Developments/Updates
Table 93. Taiho Pharmaceutical Co., Ltd. Corporation Information
Table 94. Taiho Pharmaceutical Co., Ltd. Description and Business Overview
Table 95. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Product
Table 97. Taiho Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 98. Vertex Pharmaceuticals Incorporated Corporation Information
Table 99. Vertex Pharmaceuticals Incorporated Description and Business Overview
Table 100. Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Vertex Pharmaceuticals Incorporated Aurora Kinase A Product
Table 102. Vertex Pharmaceuticals Incorporated Recent Developments/Updates
Table 103. Vichem Chemie Research Ltd. Corporation Information
Table 104. Vichem Chemie Research Ltd. Description and Business Overview
Table 105. Vichem Chemie Research Ltd. Aurora Kinase A Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Vichem Chemie Research Ltd. Aurora Kinase A Product
Table 107. Vichem Chemie Research Ltd. Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Aurora Kinase A Distributors List
Table 111. Aurora Kinase A Customers List
Table 112. Aurora Kinase A Market Trends
Table 113. Aurora Kinase A Growth Drivers
Table 114. Aurora Kinase A Market Challenges
Table 115. Aurora Kinase A Market Restraints
Table 116. Global Aurora Kinase A Sales Forecast by Type (2022-2027) & (K Pcs)
Table 117. Global Aurora Kinase A Sales Market Share Forecast by Type (2022-2027)
Table 118. Global Aurora Kinase A Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 119. Global Aurora Kinase A Revenue Market Share Forecast by Type (2022-2027)
Table 120. Global Aurora Kinase A Sales Forecast by Application (2022-2027) & (K Pcs)
Table 121. Global Aurora Kinase A Sales Market Share Forecast by Application (2022-2027)
Table 122. Global Aurora Kinase A Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 123. Global Aurora Kinase A Revenue Market Share Forecast by Application (2022-2027)
Table 124. Global Aurora Kinase A Sales Forecast by Region (2022-2027) & (K Pcs)
Table 125. Global Aurora Kinase A Sales Market Share Forecast by Region (2022-2027)
Table 126. Global Aurora Kinase A Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 127. Global Aurora Kinase A Revenue Market Share Forecast by Region (2022-2027)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Aurora Kinase A
Figure 2. Global Aurora Kinase A Market Share by Type in 2020 & 2027
Figure 3. AMG-900 Product Picture
Figure 4. Danusertib Product Picture
Figure 5. ENMD-2076 Product Picture
Figure 6. Ilorasertib Product Picture
Figure 7. Others Product Picture
Figure 8. Global Aurora Kinase A Market Share by Application in 2020 & 2027
Figure 9. Ovarian Cancer
Figure 10. Anaplastic Large Cell Lymphoma
Figure 11. Brain Tumor
Figure 12. Others
Figure 13. Global Aurora Kinase A Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Aurora Kinase A Market Size 2016-2027 (US$ Million)
Figure 15. Global Aurora Kinase A Sales 2016-2027 (K Pcs)
Figure 16. Global Aurora Kinase A Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Aurora Kinase A Sales Share by Manufacturers in 2020
Figure 18. Global Aurora Kinase A Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Aurora Kinase A Players: Market Share by Revenue in 2020
Figure 20. Aurora Kinase A Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Aurora Kinase A Sales Market Share by Region (2016-2021)
Figure 22. Global Aurora Kinase A Sales Market Share by Region in 2020
Figure 23. Global Aurora Kinase A Revenue Market Share by Region (2016-2021)
Figure 24. Global Aurora Kinase A Revenue Market Share by Region in 2020
Figure 25. U.S. Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Aurora Kinase A Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Aurora Kinase A by Type (2016-2021)
Figure 50. Sales Market Share of Aurora Kinase A by Application (2016-2021)
Figure 51. Sales Market Share of Aurora Kinase A by Application in 2020
Figure 52. Revenue Share of Aurora Kinase A by Application (2016-2021)
Figure 53. Revenue Share of Aurora Kinase A by Application in 2020
Figure 54. Manufacturing Cost Structure of Aurora Kinase A
Figure 55. Manufacturing Process Analysis of Aurora Kinase A
Figure 56. Aurora Kinase A Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’